These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1712331

  • 1. [Mechanisms of the anticoagulation activity of new semi-synthetic heparinoids].
    Azarova LA, Siatkovskiĭ VA, Kaputskiĭ FN, Torgashov VI.
    Gematol Transfuziol; 1991 Apr; 36(4):23-5. PubMed ID: 1712331
    [Abstract] [Full Text] [Related]

  • 2. Effect of Sulfation and Molecular Weight on Anticoagulant Activity of Dextran.
    Drozd NN, Logvinova YS, Torlopov MA, Udoratina EV.
    Bull Exp Biol Med; 2017 Feb; 162(4):462-465. PubMed ID: 28243911
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of new heparinoids with high anticoagulant activity.
    Hatanaka K, Yoshida T, Miyahara S, Sato T, Ono F, Uryu T, Kuzuhara H.
    J Med Chem; 1987 May; 30(5):810-4. PubMed ID: 2437306
    [Abstract] [Full Text] [Related]

  • 4. Anticoagulant activity of a synthetic heparinoid in relation to molecular weight and N-sulfate content.
    Sederel LC, van der Does L, van Duijl JF, Beugeling T, Bantjes A.
    J Biomed Mater Res; 1981 Nov; 15(6):819-27. PubMed ID: 6171571
    [Abstract] [Full Text] [Related]

  • 5. [Dependence of the anticoagulant activity of starch and inulin on their degree of sulfonation].
    Drozd NN, Torlopov MA, Kuzhim AA, Makarov VA.
    Eksp Klin Farmakol; 2012 Nov; 75(6):31-5. PubMed ID: 22891439
    [Abstract] [Full Text] [Related]

  • 6. Heparanase modulates heparinoids anticoagulant activities via non-enzymatic mechanisms.
    Katz BZ, Muhl L, Zwang E, Ilan N, Herishanu Y, Deutsch V, Naparstek E, Vlodavsky I, Preissner KT.
    Thromb Haemost; 2007 Dec; 98(6):1193-9. PubMed ID: 18064313
    [Abstract] [Full Text] [Related]

  • 7. Anticoagulant and antiprotease activities of a heparinoid sulfated glucoside-bearing polymer.
    Onishi M, Miyashita Y, Motomura T, Yamashita S, Sakamoto N, Akashi M.
    J Biomater Sci Polym Ed; 1998 Dec; 9(9):973-84. PubMed ID: 9747989
    [Abstract] [Full Text] [Related]

  • 8. Ecarin clotting time is sensitive to heparinoids: comparison of two different techniques.
    Demir M, Iqbal O, Untch B, Hoppensteadt DA, Gaikwad BS, Fareed J.
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):38-43. PubMed ID: 11190903
    [Abstract] [Full Text] [Related]

  • 9. [Antithrombin activity and prolongation of thrombin time; comparative study of heparin and of some synthetic heparinoids].
    BURSTEIN M, GUINAND A.
    Arch Int Pharmacodyn Ther; 1955 Jun 01; 102(1-2):96-104. PubMed ID: 13239250
    [No Abstract] [Full Text] [Related]

  • 10. [Anticoagulant activity of low-molecular-weight sulfated derivatives of galactomannan from Cyamopsis tetragonoloba (L.) seeds].
    Mestechkina NM, Shcherbukhin VD, Bannikova GE, Varlamov VP, Drozd NN, Tolstenkov AS, Makarov VA, Tikhonov VE.
    Prikl Biokhim Mikrobiol; 2008 Jun 01; 44(1):111-6. PubMed ID: 18491607
    [Abstract] [Full Text] [Related]

  • 11. [The anticoagulant and fibrinolytic activity of dextran sulphate (MDS) (author's transl)].
    Matsuoka M, Jinbo C, Watanabe T, Nonura J, Sakuragawa N.
    Rinsho Ketsueki; 1973 Aug 01; 14(8):882-90. PubMed ID: 4128641
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical use of heparin-heparinoid-mixtures].
    Hörder MH, Stier WD, Brunswig D.
    Arzneimittelforschung; 1969 Nov 01; 19(11):1873-6. PubMed ID: 4190000
    [No Abstract] [Full Text] [Related]

  • 13. [Basic principles anticoagulant therapy].
    Mammen EF.
    Internist (Berl); 1969 Jan 01; 10(1):2-8. PubMed ID: 4190310
    [No Abstract] [Full Text] [Related]

  • 14. Modulation of protein C activation by histones, platelet factor 4, and heparinoids: new insights into activated protein C formation.
    Kowalska MA, Zhao G, Zhai L, David G, Marcus S, Krishnaswamy S, Poncz M.
    Arterioscler Thromb Vasc Biol; 2014 Jan 01; 34(1):120-6. PubMed ID: 24177324
    [Abstract] [Full Text] [Related]

  • 15. [On the fibrinolytic effect of heparin and heparinoids].
    Naegeli T, Matis P.
    Zentralbl Chir; 1965 Jun 05; 90(23):881-3. PubMed ID: 4157844
    [No Abstract] [Full Text] [Related]

  • 16. Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C.
    Fernández JA, Petäjä J, Griffin JH.
    Thromb Haemost; 1999 Nov 05; 82(5):1462-8. PubMed ID: 10595639
    [Abstract] [Full Text] [Related]

  • 17. Structure-activity relationship of antithrombotic polysaccharide derivatives.
    Franz G, Alban S.
    Int J Biol Macromol; 1995 Dec 05; 17(6):311-4. PubMed ID: 8789331
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of action of low molecular weight heparins and heparinoids.
    Ofosu FA, Barrowcliffe TW.
    Baillieres Clin Haematol; 1990 Jul 05; 3(3):505-29. PubMed ID: 1703023
    [No Abstract] [Full Text] [Related]

  • 19. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation.
    Zmuda K, Neofotistos D, Ts'ao CH.
    Am J Clin Pathol; 2000 May 05; 113(5):725-31. PubMed ID: 10800406
    [Abstract] [Full Text] [Related]

  • 20. [Heparinoid and heparin; anticoagulant effects of dexulate, a dextran sulfate preparation].
    ARGE E.
    Ugeskr Laeger; 1957 Feb 28; 119(9):248-51. PubMed ID: 13422709
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.